Home/Filings/4/0001209191-23-031260
4//SEC Filing

Garland Jonathan Todd 4

Accession 0001209191-23-031260

CIK 0001831915other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 7:02 PM ET

Size

15.0 KB

Accession

0001209191-23-031260

Insider Transaction Report

Form 4
Period: 2023-05-18
Garland Jonathan Todd
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-05-18+7,8047,804 total
  • Tax Payment

    Common Stock

    2023-05-18$6.69/sh717$4,7975,887 total
  • Tax Payment

    Common Stock

    2023-05-18$6.69/sh3,040$20,3384,764 total
  • Exercise/Conversion

    Common Stock

    2023-05-18+1,8406,604 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-05-187,80423,413 total
    Common Stock (7,804 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-05-181,84042,340 total
    Common Stock (1,840 underlying)
Footnotes (4)
  • [F1]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
  • [F3]The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.
  • [F4]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.

Issuer

Cytek Biosciences, Inc.

CIK 0001831915

Entity typeother

Related Parties

1
  • filerCIK 0001924824

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 7:02 PM ET
Size
15.0 KB